MGRO Share Price Performance
Recent MGRO News & Updates
No updates
MustGrow Biologics Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.10
- Gross Margin
- 13.34%
- Net Profit Margin
- -131.46%
- Debt/Equity Ratio
- 475.4%
MustGrow Biologics Corp. Competitors
About MGRO
- Founded
- 2014
- Employees
- n/a
- CEO
- WebsiteView website
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
Canadian Market Performance
- 7 Days: -0.5%
- 3 Months: 10.1%
- 1 Year: 15.6%
- Year to Date: 10.0%
Over the last 7 days, the market has remained flat, although notably the Materials sector declined by 4.2%. Meanwhile, the market is actually up 16% over the past year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading